INC Research selects TransPerfect’s Trial Interactive as eTMF solution
INC Research, a therapeutically focused CRO, has selected Trial Interactive as its global electronic Trial Master File (eTMF) solution, according to TransPerfect, a provider of e-clinical technologies and creator of Trial Interactive. Trial Interactive is a secure, web-based platform that reduces the redundancies inherent in paper-based TMF management.
“We chose Trial Interactive as our eTMF solution because it offers the greatest compatibility with current and potential customers,” said Todd Esporas, executive director of clinical development services, INC Research. “The system creates efficiencies across our organization and further demonstrates our position as a leading partner to the biopharmaceutical industry. By embracing the latest, most sophisticated technology to accelerate drug development, we are able to deliver clinical trials on behalf of our customers more efficiently.”
As a global CRO, optimizing the collection and management of TMFs worldwide is a critical task for INC Research. Trial Interactive enables INC Research to deliver trials more efficiently by allowing real-time access to global project documentation, eliminating much of the travel and shipping associated with TMF reviews and reconciliation and providing a real-time metrics dashboard to enhance communications with customers and stakeholders. Trial Interactive’s interface is available in more than 20 languages, which will enable INC Research to deploy the solution in the local language of the end user, making it ideal for global study teams, sponsors and investigative site personnel involved in the conduct of multinational clinical trials.
Michael Smyth, general manager of TransPerfect’s life science solutions division, added, “INC’s global reach and commitment to utilizing technology should only serve to benefit their study sponsors as they seek to become more efficient in conducting global clinical trials.”